Cases 51 - 60 of 146
Genzyme Corp. et al v. Dr. Reddy's Laboratories, Inc. et al
as 1:2019cv02045
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff:
The Regents of the University of Michigan and Genzyme Corp.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. et al
as 1:2019cv02053
Defendant:
MSN Laboratories Private Limited, Dr. Reddys Laboratories, Inc., Hetero USA Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. DR. REDDY'S LABORATORIES, INC. et al
as 3:2019cv18764
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
DR. REDDY'S LABORATORIES, LTD. and DR. REDDY'S LABORATORIES, INC.
Cause Of Action: 15 U.S.C. § 1126
BRISTOL-MYERS SQUIBB COMPANY v. DR. REDDYS LABORATORIES, LTD. et al
as 3:2019cv18686
Defendant:
DR. REDDYS LABORATORIES, LTD., DR. REDDYS LABORATORIES, INC., DR. REDDY'S LABORATORIES, LTD. and others
Plaintiff:
BRISTOL-MYERS SQUIBB COMPANY
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v Dr. Reddy's Laboratories, Ltd. et al
as 1:2019cv01495
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ASTRAZENECA LP et al v. DR. REDDY'S LABORATORIES, LTD. et al
as 2:2019cv15739
Defendant:
DR. REDDY'S LABORATORIES, LTD. and DR. REDDY'S LABORATORIES, INC.
Plaintiff:
ASTRAZENECA UK LIMITED, ASTRAZENECA LP and ASTRAZENECA PHARMACEUTICALS LP
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD. et al
as 2:2019cv15343
Defendant:
DR. REDDY'S LABORATORIES, LTD. and DR. REDDY'S LABORATORIES, INC.
Plaintiff:
CELGENE CORPORATION
Cause Of Action: 28 U.S.C. § 1338
Astellas US LLC et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2019cv01160
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff:
Gilead Sciences, Inc., Astellas US LLC and Astellas Pharma US, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
